Upstream Bio, Inc. Contracts & Agreements
23 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (1)
- Human Resources (8)
- Intellectual Property (3)
- Real Estate (2)
- Uncategorized (3)
- Offer Letter, by and between the registrant and Michael Paul Gray, M.B.A., dated March 11, 2024 (Filed With SEC on October 7, 2024)
- Offer Letter, by and between the registrant and E. Rand Sutherland, M.D., M.P.H., dated March 27, 2024, as amended (Filed With SEC on October 7, 2024)
- Non-Employee Director Compensation Policy (Filed With SEC on October 7, 2024)
- Form of Indemnification Agreement, by and between the registrant and each of its directors and executive officers (Filed With SEC on October 7, 2024)
- Upstream Bio, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on October 7, 2024)
- Upstream Bio, Inc. 2024 Stock Option and Incentive Plan and form of award agreements thereunder (Filed With SEC on October 7, 2024)
- Form of Underwriting Agreement (Filed With SEC on October 7, 2024)
- Exclusive License Agreement, by and between the registrant and Maruho Co., Ltd., dated October 14, 2021, as amended (Filed With SEC on September 18, 2024)
- Lease Agreement, by and between the registrant and BXP Waltham Woods LLC, dated as of July 3, 2024 (Filed With SEC on September 18, 2024)
- Sublease Agreement, by and between the registrant and Imaging Endpoints, LLC, dated as of December 27, 2021, as amended (Filed With SEC on September 18, 2024)
- License Agreement, by and between the registrant and NWALP TPOP Property Owner LLC, dated as of September 13, 2022, as amended (Filed With SEC on September 18, 2024)
- License Agreement, by and between the registrant and Lonza Sales AG, dated October 21, 2021, as amended (Filed With SEC on September 18, 2024)
- Specimen Common Stock Certificate (Filed With SEC on September 18, 2024)
- Letter Agreement, by and among the registrant, Astellas Pharma Inc. and Regeneron Pharmaceuticals Inc., dated October 19, 2021 (Filed With SEC on September 18, 2024)
- Asset Purchase Agreement, by and between the registrant and Astellas Pharma Inc., dated October 14, 2021 (Filed With SEC on September 18, 2024)
- Form of Employment Agreement for Executive Officers, to be in effect upon the completion of this offering (Filed With SEC on September 18, 2024)
- Separation Agreement, by and between the registrant and Jennifer Beachell, dated February 26, 2024 (Filed With SEC on September 18, 2024)
- Separation Agreement, by and between the registrant and Samantha Truex, M.B.A., dated March 13, 2024 (Filed With SEC on September 18, 2024)
- Compensation Recovery Policy (Filed With SEC on September 18, 2024)
- Executive Severance Plan (Filed With SEC on September 18, 2024)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on September 18, 2024)
- 2021 Stock Option and Grant Plan, as amended, and form of award agreements thereunder (Filed With SEC on September 18, 2024)
- Amended and Restated Investors Rights Agreement, among the registrant and certain of its stockholders, dated June 6, 2023 (Filed With SEC on September 18, 2024)
